Horizontal infection control strategy decreases methicillin-resistant staphylococcus aureus infection and eliminates bacteremia in a surgical ICU without active surveillance

Critical Care Medicine

Volumn 42, Issue 10, 2014, Pages 2151-2157

  Traa, Maria X ^a   Barboza, Lorena ^a   Doron, Shira ^a   Snydman, David R ^a   Noubary, Farzad ^a   Nasraway, Stanley A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Chlorhexidine; Decontamination; Hand hygiene; Intensive care units; Methicillin resistant Staphylococcus aureus

Indexed keywords

2 PROPANOL; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; HYDROGEN PEROXIDE; MOUTHWASH;

ADULT; ARTICLE; BACTEREMIA; BATH; BLOODSTREAM INFECTION; CATHETER INFECTION; CLINICAL EFFECTIVENESS; DISEASE SURVEILLANCE; EVIDENCE BASED PRACTICE; HAND WASHING; HEALTH CARE PLANNING; HEALTH EDUCATION; HOSPITAL READMISSION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUTH HYGIENE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PREVALENCE; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; VENTILATED PATIENT; CROSS INFECTION; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA;

BACTEREMIA; CROSS INFECTION; HUMANS; INTENSIVE CARE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS;

EID: 84914097983     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000501     Document Type: Article

References (37)

1. Jevons M P, Coe AW, Parker MT: Methicillin resistance in staphylo-cocci. Lancet 1963; 1:904-907
2. Lin MY, Hayden MK: Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: Recognition and prevention in intensive care units. Crit Care Med 2010; 38:S335-S344
3. Higgins A, Lynch M, Gethin G: Can 'search and destroy' reduce noso-comial methicillin-resistant Staphylococcus aureus in an Irish hospital? J Hosp Infect 2010; 75:120-123
4. Sangal V, Girvan EK, Jadhav S, et al: Impacts of a long-term programme of active surveillance and chlorhexidine baths on the clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit in Scotland. Int J Antimicrob Agents 2012; 40:323-331
5. Wise ME, Weber SG, Schneider A, et al: Hospital staff perceptions of a legislative mandate for methicillin-resistant Staphylococcus aureus screening. Infect Control Hosp Epidemiol 2011; 32:573-578
6. Fukuta Y, Cunningham CA, Harris PL, et al: Identifying the risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection among patients colonized with MRSA on admission. Infect Control Hosp Epidemiol 2012; 33:1219-1225
7. Jain R, Kralovic SM, Evans ME, et al: Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011; 364:1419-1430
8. Edmond MB, Wenzel RP: Screening inpatients for MRSA-case closed. N Engl J Med 2013; 368:2314-2315
9. Barratt RL, Shaban R, Moyle W: Patient experience of source isolation: Lessons for clinical practice. Contemp Nurse 2011; 39:180-193
10. Reyes K, Johnson L, Sullivan J: Impact of active surveillance on methicillin-resistant Staphylococcus aureus transmission and hospital resource utilisation. J Hosp Infect 2010; 74:232-237
11. Morgan DJ, Pineles L, Shardell M, et al: The effect of contact precautions on healthcare worker activity in acute care hospitals. Infect Control Hosp Epidemiol 2013; 34:69-73
12. R Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Available at: http://www.R-project.org. Accessed December 22, 2013
13. Centers for Disease Control and Prevention: Active Bacterial Core Surveillance Report, Emerging Infection Program Network, Methicillin resistant Staphylococcus aureus. Atlanta, GA: Centers for Disease Control and Prevention, 2011
14. Hanberger H, Walther S, Leone M, et al; EPIC II Group of Investigators: Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: Results from the EPIC II study. Int J Antimicrob Agents 2011; 38:331-335
15. Zhanel GG, Decorby M, Nichol KA, et al: Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant entero-cocci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006). Can J Infect Dis Med Microbiol 2008; 19:243-249
16. Dantes R, Belfower R, Aragon D, et al: National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013; 21:1970-1978
17. Coello R, Glynn JR, Gaspar C, et al: Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 1997; 37:39-46
18. Feng PJ, Kallen AJ, Ellingson K, et al: Clinical incidence of methicillin-resistant Staphylococcus aureus (MRSA) colonization or infection as a proxy measure for MRSA transmission in acute care hospitals. Infect Control Hosp Epidemiol 2011; 32:20-25
19. Lawes T, Edwards B, López-Lozano J-M, et al: Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: Retrospective cohort study and time-series intervention analysis. BMJ Open 2012; 2:e000797
20. Huskins WC, Huckabee CM, O'Grady NP, et al; STAR∗ICU Trial Investigators: Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364:1407-1418
21. Gould IM, MacKenzie FM, MacLennan G, et al: Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents 2007; 29:536-543
22. Kurup A, Chlebicka N, Tan KY, et al: Active surveillance testing and decontamination strategies in intensive care units to reduce methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 2010; 38:361-367
23. van der Zee A, Hendriks WD, Roorda L, et al: Review of a major epidemic of methicillin-resistant Staphylococcus aureus: The costs of screening and consequences of outbreak management. Am J Infect Control 2013; 41:204-209
24. Vos MC, Behrendt MD, Melles DC, et al: 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol 2009; 30:977-984
25. Saint S, Higgins LA, Nallamothu BK, et al: Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003; 31:354-356
26. Huang SS, Septimus E, Kleinman K, et al; CDC Prevention Epicenters Program; AHRQ DECIDE Network and Healthcare-Associated Infections Program: Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368:2255-2265
27. Livorsi D, Stenehjem E, Gaynes R: Multidrug-Resistant Bacteria: The Emerging Crisis. New York, NY, Springer New York, 2012, pp 47-88
28. Nasraway SA: Improving hand hygiene performance in a surgical ICU: A novel method for data collection to change physician behavior. 33rd International Symposium on Intensive Care and Emergency Medicine. Brussels, Belgium, 2013
29. DiDiodato G: Has improved hand hygiene compliance reduced the risk of hospital-acquired infections among hospitalized patients in Ontario? Analysis of publicly reported patient safety data from 2008 to 2011. Infect Control Hosp Epidemiol 2013; 34:605-610
30. Huang SS, Yokoe DS, Hinrichsen VL, et al: Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43:971-978
31. Rubin C, Louthan RB, Wessels E, et al: Chlorhexidine gluconate: To bathe or not to bathe? Crit Care Nurs Q 2013; 36:233-236
32. Climo MW, Yokoe DS, Warren DK, et al: Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368:533-542
33. Climo MW, Sepkowitz KA, Zuccotti G, et al: The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med 2009; 37: 1858-1865
34. Liippo J, Kousa P, Lammintausta K: The relevance of chlorhexidine contact allergy. Contact Dermatitis 2011; 64:229-234
35. Cheng CE, Kroshinsky D: Iatrogenic skin injury in hospitalized patients. Clin Dermatol 2011; 29:622-632
36. Costello JM, Morrow DF, Graham DA, et al: Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121: 915-923
37. Wnters B, Dorman T: Patient-safety and quality initiatives in the intensive-care unit. Curr Opin Anaesthesiol 2006; 19:140-145